Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly

1996 ◽  
Vol 156 (2) ◽  
pp. 205-208 ◽  
Author(s):  
P. O. Honkanen
Keyword(s):  
Influenza Vaccine ◽  
Pneumococcal Vaccine ◽  
The Elderly

Adverse Reactions to Influenza Vaccine Alone or with Pneumococcal Vaccine in the Elderly

2004 ◽  
Vol 52 (7) ◽  
pp. 1219-1220 ◽  
Author(s):  
Emanuela Perucchini ◽  
Silvia Consonni ◽  
Maria Cristina Sandrini ◽  
Luigi Bergamaschini ◽  
Carlo Vergani
Keyword(s):  
Influenza Vaccine ◽  
Pneumococcal Vaccine ◽  
Adverse Reactions ◽  
The Elderly

scholarly journals Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies

2002 ◽  
Vol 128 (3) ◽  
pp. 445-455 ◽  
Author(s):  
M. H. KYAW ◽  
B. WAYNE ◽  
J. CHALMERS ◽  
I. G. JONES ◽  
H. CAMPBELL
Keyword(s):  
Primary Care ◽  
Influenza Vaccine ◽  
Pneumococcal Vaccine ◽  
Vaccine Coverage ◽  
Hospital Setting ◽  
Pneumococcal Vaccination ◽  
The Elderly ◽  
Risk Patients ◽  
General Practices ◽  
Vaccine Distribution

A survey of the coverage, distribution and the factors associated with use of influenza and pneumococcal vaccines among general practitioners (GPs) in primary care and in hospital settings was carried out in 53 general practices in Scotland taking part in the ‘Continuous Morbidity Recording’ (CMR) programme. The annual vaccine distribution increased substantially among 53 general practices from 1993 to 1999 and in Scotland as a whole from 1984 to 1999. From the questionnaire, overall coverage was 43% (95% CI 38–48) for influenza vaccine in the 2000–1 season and 13% (95% CI 9–16) for pneumococcal vaccine in the last 5 year period, in high-risk patients recommended for these vaccines by the Department of Health (DoH). Influenza vaccine coverage was highest in the elderly (65 years of age and above) at 62% (95% CI 59–74). Although pneumococcal vaccination is not currently recommended for all elderly, coverage of this vaccine was also higher in this group (22%, 95% CI 16–29). In the majority of patients (influenza vaccine, 98% and pneumococcal vaccine, 94%), vaccination was carried out in general practice. Only 2% of patients had received pneumococcal vaccination in a hospital setting. The level of influenza and pneumococcal vaccination varied with the level of deprivation. Most GPs considered that the responsibility for influenza and pneumococcal vaccination lay with them. Forty-five percent of GPs reported having a written policy with set target for influenza vaccination and 11% for pneumococcal vaccination.

scholarly journals Google search behavior for meningitis and its vaccines: an infodemiological study

BMC Neurology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
John Angelo Luigi S. Perez ◽  
Adrian I. Espiritu ◽  
Roland Dominic G. Jamora
Keyword(s):  
Influenza Vaccine ◽  
Pneumococcal Vaccine ◽  
Rank Correlation ◽  
Infectious Agents ◽  
Online Behavior ◽  
Online Search ◽  
Search Volume ◽  
Search Patterns ◽  
Google Search ◽  
The Relationship

Abstract Background The internet has made significant contributions towards health education. Analyzing the pattern of online behavior regarding meningitis and vaccinations may be worthwhile. It is hypothesized that the online search patterns in meningitis are correlated with its number of cases and the search patterns of its related vaccines. Methods This was an infodemiological study that determined the relationship among online search interest in meningitis, its worldwide number of cases and its associated vaccines. Using Google Trends™ Search Volume Indices (SVIs), we evaluated the search queries “meningitis,” “pneumococcal vaccine,” “BCG vaccine,” “meningococcal vaccine” and “influenza vaccine” in January 2021, covering January 2008 to December 2020. Spearman rank correlation was used to determine correlations between these queries. Results The worldwide search interest in meningitis from 2008 to 2020 showed an average SVI of 46 ± 8.8. The most searched topics were symptoms, vaccines, and infectious agents with SVIs of 100, 52, and 39, respectively. The top three countries with the highest search interest were Ghana, Kazakhstan, and Kenya. There were weak, but statistically significant correlations between meningitis and the BCG (ρ = 0.369, p < 0.001) and meningococcal (ρ = 0.183, p < 0.05) vaccines. There were no statistically significant associations between the number of cases, influenza vaccine, and pneumococcal vaccine. Conclusion The relationships among the Google SVIs for meningitis and its related vaccines and number of cases data were inconsistent and remained unclear. Future infodemiological studies may expand their scopes to social media, semantics, and big data for more robust conclusions.

When to use the new pneumococcal vaccine

1990 ◽  
Vol 28 (8) ◽  
pp. 31-32
Keyword(s):  
United States ◽  
Pneumococcal Vaccine ◽  
Pneumococcal Disease ◽  
Pneumococcal Pneumonia ◽  
Pneumococcal Infection ◽  
The Elderly ◽  
The United States ◽  
Cell Disease ◽  
Large Groups ◽  
Special Risk

Pneumococcal pneumonia probably affects about one in every thousand adults each year. Like other serious pneumococcal infection, it is more common and severe in the elderly, in those without a functional spleen (including patients with sickle-cell disease,1) and in patients with a variety of chronic diseases. In the United States a 23-valent pneumococcal vaccine was introduced in 1983, replacing a 14-valent vaccine; it is now recommended there for large groups of people.2 This newer 23-valent vaccine (Pneumovax-II - MSD) was licensed in Britain last May. Its use should be considered for those at special risk of pneumococcal disease.3–5

scholarly journals Influenza vaccine coverage and the attack rate of influenza-like illness among the elderly in Portugal: is there a correlation?

2007 ◽  
Vol 12 (20) ◽  
Author(s):  
B Nunes ◽  
I Falcao ◽  
A Machado ◽  
E Rodrigues ◽  
J Marinho Falcao
Keyword(s):  
Influenza Vaccine ◽  
Attack Rate ◽  
Vaccine Coverage ◽  
The Elderly ◽  
European Countries ◽  
Influenza Like Illness

Vaccination of the elderly (&gt;=65 years of age) against influenza is recommended in all European countries

scholarly journals Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic

2000 ◽  
Vol 125 (2) ◽  
pp. 393-397 ◽  
Author(s):  
Y. DEGUCHI ◽  
Y. TAKASUGI ◽  
K. NISHIMURA
Keyword(s):  
Nursing Homes ◽  
Influenza Vaccine ◽  
Influenza A ◽  
Hospital Admissions ◽  
Influenza Virus Infection ◽  
Severe Infection ◽  
The Elderly ◽  
Trivalent Influenza Vaccine ◽  
Homes For The Elderly ◽  
Vaccine Effect

Influenza vaccine effect on the occurrence and severity of influenza virus infection in a population residing in nursing homes for the elderly was studied as a cohort study during an influenza A (H3N2) epidemic in Japan. Of 22462 individuals living in 301 welfare nursing homes, 10739 voluntarily received inactivated, sub-unit trivalent influenza vaccine in a programme supported by the Osaka Prefectural Government. There were statistically significantly fewer cases of influenza, hospital admissions due to severe infection, and deaths due to influenza in the vaccinated cohort compared to the unvaccinated controls. No serious adverse reactions to vaccination were recorded. Thus influenza vaccination is effective for preventing influenza disease in persons aged 65 years and over, and should be an integral part of the care of this population residing in nursing homes.

Sign in / Sign up

Export Citation Format

Share Document